Spectrum Pharmaceuticals
SPPI
$1.03
Share price
0.00%
Change (1 day)
17.05%
Change (1 year)
Categories
Spectrum Pharmaceuticals (SPPI) - Total debt
Total debt on the balance sheet as of March 2023 : $28.84 M
According to Spectrum Pharmaceuticals 's latest financial reports the company's total debt is $28.84 M. A company’s total debt is the sum of all current and non-current debts.
Spectrum Pharmaceuticals - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $28.66 M | 2136.04% |
| 2021-12-31 | $1.28 M | -16.97% |
| 2020-12-31 | $1.54 M | -61.92% |
| 2019-12-31 | $4.05 M | |
| 2017-12-31 | $38.22 M | -60.61% |
| 2016-12-31 | $97.04 M | -4.44% |
| 2015-12-31 | $0.10 B | 5.45% |
| 2014-12-31 | $96.29 M | 5.27% |
| 2013-12-31 | $91.48 M | 21.97% |
| 2012-12-31 | $75 M | 24329.97% |
| 2011-12-31 | $0.3 M | 667.5% |
| 2010-12-31 | $0.04 M | -42.03% |
| 2009-12-31 | $0.06 M | -99.09% |
| 2008-12-31 | $7.59 M | |
| 2003-12-31 | $0.14 M | -68.76% |
| 2002-12-31 | $0.46 M | -62.98% |
| 2001-12-31 | $1.25 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 101,605.96% | 🇺🇸 USA |
 Novartis NVS | $26.34 B | 91,259.22% | 🇨🇭 Switzerland |
 Pfizer PFE | $70.84 B | 245,548.40% | 🇺🇸 USA |
 Abbott Laboratories ABT | $15.62 B | 54,088.63% | 🇺🇸 USA |
 Biogen BIIB | $7.33 B | 25,344.52% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $41.46 B | 143,672.54% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $22.93 B | 79,431.55% | 🇬🇧 UK |
 Seagen
SGEN | $0.11 B | 293.51% | 🇺🇸 USA |
 Curis CRIS | $2.79 M | -90.31% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $20.15 B | 69,778.64% | 🇮🇱 Israel |